Pharmacogenetic Testing for Warfarin Advances
Pharmacogenetics has the potential to avoid some of the three quarter million adverse drug events seen each year.
Read MorePosted by Clinical Lab Products | Jul 1, 2009 | Cancer, Miscellaneous |
Pharmacogenetics has the potential to avoid some of the three quarter million adverse drug events seen each year.
Read MorePosted by Clinical Lab Products | May 26, 2009 | Cancer, Miscellaneous |
AltheaDx announces that they have successfully passed the State of California survey for CLIA (Clinical Laboratory Improvement Amendments) certification.
Read MorePosted by Clinical Lab Products | Mar 3, 2009 | Cancer, Miscellaneous |
Genentech Inc on Monday touted its culture of innovative research and offered detailed long-term sales projections as it made its case to Wall Street on what it considers a low buyout bid from drug maker Roche.
Read MorePosted by Clinical Lab Products | Feb 24, 2009 | Cancer, Miscellaneous |
Testing of blood specimens may detect abnormal white blood cells in patients years before the chronic form of lymphocytic leukemia (CLL) develops, according to research published in the current issue of the New England Journal of Medicine.
Read MorePosted by Clinical Lab Products | Feb 12, 2009 | Cancer, Miscellaneous |
ViraCor Laboratories announces the launch of a new cytomegalovirus (CMV) antiviral resistance test that provides diagnosis days faster than other tests on the market.
Read More